Sveriges mest populära poddar

Ep. 3 - Surveying the Landscape for Biopharmas

15 min•28 april 2020

BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.

Reach us by sending a text

Fler avsnitt av BioCentury This Week

Ep. 357 - Deal-O-rama, Gilead and Tallon's U.K. vision

30 mars•29 min

Ep. 356 - Arrowhead’s arc. Plus: AI in biotech venture, Synnovation, MFN

24 mars•34 min

Ep. 355 - Capital market mood, Xenon data, Friedreich ataxia pipeline

17 mars•25 min

Ep. 354 - East-West Summit Takeaways

14 mars•26 min

Ep. 353 - Prasad Departure and Future of Fibrosis Therapies

9 mars•37 min

Ep. 352 - A Multipolar Biopharma World; Rare Disease Spotlight

3 mars•35 min

Ep. 351 - Gilead's Arcellx Buy. Plus: ctDNA as Surrogate Endpoint

24 feb.•35 min

Ep. 350 - Oral SERD Spotlight. Plus: Setbacks at FDA

17 feb.•26 min

Ep. 349 - Start-up Spotlight, Compounding Wegovy & Neuropysch

10 feb.•34 min

Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules

3 feb.•31 min

BioCentury This Week med BioCentury finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.